LM2I | MedChemExpress (MCE)

LM2I is a derivative of Spinosyn A (SPA). LM2I is argininosuccinate synthase (ASS1) enzyme activator, and tumor inhibitor that directly interact with ASS1. LM2I has significant antiproliferative activity in seven colorectal cancer cell-lines and xenograft tumors of colorectal cancer. LM2I inhibits colorectal cancer cell growth via the EGFR pathway^[1].

Price Not Available 1 mg LM2I | MedChemExpress (MCE) Supplier Page

Trivial name	LM2I
Catalog Number	HY-156112
Research Area	Cancer
CAS#	2055494-50-1
Purity	≥98.00%
SMILES	O=C(C1=C[C@]2([H])[C@](C=C[C@@]3([H])[C@@]2([H])C[C@H](O[C@@H]4O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]4OC)C3)([H])[C@]1([H])C5)[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](N(CC(O)CN7CCNCC7)C)CC6)CCC[C@H](CC)OC5=O
PubChem Chemical Structure ID	168679851
Size	1 mg
Supplier Page	https://www.medchemexpress.com/lm2i.html